OTCMKTS:EVARF Lombard Medical (EVARF) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisChart About Lombard Medical Stock (OTCMKTS:EVARF) Get Lombard Medical alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Lombard Medical was a medical device company focused on products for the minimally invasive treatment of abdominal aortic aneurysms (AAAs). Its principal product was the Aorfix endovascular stent graft, designed to reinforce weakened sections of the aorta and provide an alternative to open surgical repair. The company also developed delivery systems and related technologies intended to help physicians position and deploy endovascular grafts during aneurysm repair procedures. Aorfix was marketed internationally and received regulatory clearances, including approval for use in the United States. Lombard Medical was headquartered in the United Kingdom and served hospitals and vascular specialists in multiple international markets. The company was acquired by MicroPort Scientific Corporation in 2016, after which Lombard Medical became part of MicroPort’s medical-device operations.AI Generated. May Contain Errors. Read More Receive EVARF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Lombard Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. EVARF Stock News HeadlinesCapital Healthcare Properties and HSG Medical acquire Lombard medical office building for $3MMay 9, 2025 | bizjournals.comWhy travel insurance is essential for international tripsOctober 12, 2024 | msn.comElon's next millionaires start October 24?SpaceX minted 4,400 millionaires in a single day, and Tesla has turned more than 5,000 employees into millionaires. One welder's $10,000 stock package made him a millionaire on IPO day. Former Wall Street CEO Dylan Jovine says Elon Musk's next venture could outsize everything he's built before. It runs on an obscure AI firm Musk has relied on since 2012, supplying crucial technology to Tesla, Starlink and SpaceX. | Behind the Markets (Ad)Cherish Lombard: Mobile native, mom, wife, animal advocate and WKRG News 5 evening anchorOctober 11, 2024 | msn.comIndia's ICICI Lombard posts Q1 profit jump on motor, health insurance boostJuly 20, 2024 | reuters.comWeekend Break: WickedBall Chicago in Lombard has something for everyoneApril 16, 2024 | msn.comTrip cancelled due to Israel-Iran conflict? Here’s what your travel insurance company will sayApril 15, 2024 | msn.com18-year-old man charged with fatally shooting popular limo driver in AustinFebruary 8, 2024 | chicago.suntimes.comCSee More Headlines EVARF Stock Analysis - Frequently Asked Questions How were Lombard Medical's earnings last quarter? Lombard Medical, Inc. (OTCMKTS:EVARF) posted its quarterly earnings results on Thursday, October, 27th. The medical equipment provider reported ($0.37) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.27) by $0.11. The medical equipment provider had revenue of $3.04 million for the quarter, compared to analysts' expectations of $3.16 million. What other stocks do shareholders of Lombard Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Lombard Medical investors own include Celldex Therapeutics (CLDX), Plus Therapeutics (PSTV), PayPal (PYPL), Can-Fite BioPharma (CANF), Ayala Pharmaceuticals (ADXS), Advanced Micro Devices (AMD) and Athersys (ATHX). Company Calendar Last Earnings10/27/2016Today10/13/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolOTCMKTS:EVARF Previous SymbolNASDAQ:EVAR CIKN/A Webwww.lombardmedical.com Phone44121235750800Fax44-0-12-3575-0879Employees111Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free Report This page (OTCMKTS:EVARF) was last updated on 10/7/2026 by MarketBeat.com Staff. From Our PartnersWall Street legend reveals his top AI stock before Oct. 20Marc Chaikin, the 60-year Wall Street veteran behind the Power Gauge rating system, has flagged a new AI stock...Chaikin Analytics | SponsoredThis little-known gold fund distributes cash every FridayGold pays no dividends, no interest, no yield - it just sits there. Yet investors are reportedly collecting up...Investors Alley | SponsoredTrump's about to unleash his Midterm WeaponTrump is turning the midterms into a referendum on American energy, pushing for more oil, more gas, and lower ...Monument Traders Alliance | SponsoredA Simple Guide to Options Trading While It's Still FreeA free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | SponsoredTrump's crypto bank just got approvedLast month I told investors that a Trump-backed crypto bank could be approved any day. On August 14, it was...Crypto 101 Media | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredDo this before December or regret itPorter Stansberry believes President Trump will use the December G20 Summit in Miami to unveil a radical monet...Porter & Company | SponsoredINSANE DRONE FOOTAGENew drone footage shows a mysterious factory rising at one of Elon Musk's most secure facilities, cleared and ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lombard Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lombard Medical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
